Compare CVS Health Corp (CVS) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Advanced Drainage Systems Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Advanced Drainage Systems Inc trades at $125.56 (market cap $9.51B). The key difference: CVS Health Corp is far larger — about 11.8× Advanced Drainage Systems Inc's market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Advanced Drainage Systems Inc for 43 Days on average.
| CVS | WMS | |
|---|---|---|
Market Cap | $112.49B | $9.51B |
Volume | 8,467,392 | 771,064 |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $175.38 |
52-Week Low | $70.08 | $125.33 |
Typical Hold Time | 83 Days | 43 Days |
Enterprise Value | $174.83B | $11.11B |
Dividend Yield | 3.02% | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Advanced Drainage Systems (WMS) trades at $126.21, down 2.97% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news includes the release of its 2026 Sustainability Report and a quarterly dividend declaration.
The outlook is mixed; analyst consensus targets $188.70, implying significant upside, but near-term technical pressure and a projected net cash outflow in 2026 present risks. Investment appeal hinges on execution of growth initiatives and margin stability against macroeconomic and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
